Cargando…
Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola
BACKGROUND: Plasmodium falciparum resistance to chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) has historically posed a major threat to malaria control throughout the world. The country of Angola officially replaced CQ with artemisinin-based combination therapy (ACT) as a first-line treatment i...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028775/ https://www.ncbi.nlm.nih.gov/pubmed/33827587 http://dx.doi.org/10.1186/s12936-021-03713-2 |
_version_ | 1783676004246487040 |
---|---|
author | Ebel, Emily R. Reis, Fátima Petrov, Dmitri A. Beleza, Sandra |
author_facet | Ebel, Emily R. Reis, Fátima Petrov, Dmitri A. Beleza, Sandra |
author_sort | Ebel, Emily R. |
collection | PubMed |
description | BACKGROUND: Plasmodium falciparum resistance to chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) has historically posed a major threat to malaria control throughout the world. The country of Angola officially replaced CQ with artemisinin-based combination therapy (ACT) as a first-line treatment in 2006, but malaria cases and deaths have recently been rising. Many classic resistance mutations are relevant for the efficacy of currently available drugs, making it important to continue monitoring their frequency in Angola. METHODS: Plasmodium falciparum DNA was sampled from the blood of 50 hospital patients in Cabinda, Angola from October-December of 2018. Each infection was genotyped for 13 alleles in the genes crt, mdr1, dhps, dhfr, and kelch13, which are collectively involved in resistance to six common anti-malarials. To compare frequency patterns over time, P. falciparum genotype data were also collated from studies published from across Angola in the last two decades. RESULTS: The two most important alleles for CQ resistance, crt 76T and mdr1 86Y, were found at respective frequencies of 71.4% and 6.5%. Historical data suggest that mdr1 N86 has been steadily replacing 86Y throughout Angola in the last decade, while the frequency of crt 76T has been more variable across studies. Over a third of new samples from Cabinda were ‘quintuple mutants’ for SP resistance in dhfr/dhps, with a sixth mutation at dhps A581G present at 9.6% frequency. The markers dhfr 51I, dhfr 108N, and dhps 437G have been nearly fixed in Angola since the early 2000s, whereas dhfr 59R may have risen to high frequency more recently. Finally, no non-synonymous polymorphisms were detected in kelch13, which is involved in artemisinin resistance in Southeast Asia. CONCLUSIONS: Genetic markers of P. falciparum resistance to CQ are likely declining in frequency in Angola, consistent with the official discontinuation of CQ in 2006. The high frequency of multiple genetic markers of SP resistance is consistent with the continued public and private use of SP. In the future, more complete haplotype data from mdr1, dhfr, and dhps will be critical for understanding the changing efficacy of multiple anti-malarial drugs. These data can be used to support effective drug policy decisions in Angola. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-021-03713-2. |
format | Online Article Text |
id | pubmed-8028775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80287752021-04-08 Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola Ebel, Emily R. Reis, Fátima Petrov, Dmitri A. Beleza, Sandra Malar J Research BACKGROUND: Plasmodium falciparum resistance to chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) has historically posed a major threat to malaria control throughout the world. The country of Angola officially replaced CQ with artemisinin-based combination therapy (ACT) as a first-line treatment in 2006, but malaria cases and deaths have recently been rising. Many classic resistance mutations are relevant for the efficacy of currently available drugs, making it important to continue monitoring their frequency in Angola. METHODS: Plasmodium falciparum DNA was sampled from the blood of 50 hospital patients in Cabinda, Angola from October-December of 2018. Each infection was genotyped for 13 alleles in the genes crt, mdr1, dhps, dhfr, and kelch13, which are collectively involved in resistance to six common anti-malarials. To compare frequency patterns over time, P. falciparum genotype data were also collated from studies published from across Angola in the last two decades. RESULTS: The two most important alleles for CQ resistance, crt 76T and mdr1 86Y, were found at respective frequencies of 71.4% and 6.5%. Historical data suggest that mdr1 N86 has been steadily replacing 86Y throughout Angola in the last decade, while the frequency of crt 76T has been more variable across studies. Over a third of new samples from Cabinda were ‘quintuple mutants’ for SP resistance in dhfr/dhps, with a sixth mutation at dhps A581G present at 9.6% frequency. The markers dhfr 51I, dhfr 108N, and dhps 437G have been nearly fixed in Angola since the early 2000s, whereas dhfr 59R may have risen to high frequency more recently. Finally, no non-synonymous polymorphisms were detected in kelch13, which is involved in artemisinin resistance in Southeast Asia. CONCLUSIONS: Genetic markers of P. falciparum resistance to CQ are likely declining in frequency in Angola, consistent with the official discontinuation of CQ in 2006. The high frequency of multiple genetic markers of SP resistance is consistent with the continued public and private use of SP. In the future, more complete haplotype data from mdr1, dhfr, and dhps will be critical for understanding the changing efficacy of multiple anti-malarial drugs. These data can be used to support effective drug policy decisions in Angola. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-021-03713-2. BioMed Central 2021-04-07 /pmc/articles/PMC8028775/ /pubmed/33827587 http://dx.doi.org/10.1186/s12936-021-03713-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ebel, Emily R. Reis, Fátima Petrov, Dmitri A. Beleza, Sandra Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola |
title | Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola |
title_full | Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola |
title_fullStr | Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola |
title_full_unstemmed | Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola |
title_short | Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola |
title_sort | historical trends and new surveillance of plasmodium falciparum drug resistance markers in angola |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028775/ https://www.ncbi.nlm.nih.gov/pubmed/33827587 http://dx.doi.org/10.1186/s12936-021-03713-2 |
work_keys_str_mv | AT ebelemilyr historicaltrendsandnewsurveillanceofplasmodiumfalciparumdrugresistancemarkersinangola AT reisfatima historicaltrendsandnewsurveillanceofplasmodiumfalciparumdrugresistancemarkersinangola AT petrovdmitria historicaltrendsandnewsurveillanceofplasmodiumfalciparumdrugresistancemarkersinangola AT belezasandra historicaltrendsandnewsurveillanceofplasmodiumfalciparumdrugresistancemarkersinangola |